Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily nitisinone vs no treatment in alkaptonuria
2013-001633-41Phase 3Completed
- Sponsor
- University of Liverpool
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of nitisinone in alkaptonuria (AKU) (2 arms), sponsored by University of Liverpool. Primary endpoint: Primary: 24-hour urinary homogentisic acid excretion at 12 months. Started Jul 2013; status: completed.
02
Drugs
nitisinone
03
Conditions
alkaptonuria (AKU)
Beyond the preview
Go deeper on 2013-001633-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001633-41.